Skip to main content
TipRanks
Go Ultimate75% OFF

Universal Health (UHS) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

UHS Analyst Ratings

Hold
16Ratings
5Buy10Hold1Sell
Based on 16 analysts giving stock ratings to Universal Health in the past 3 months

UHS Stock 12 Month Forecast

CHF165.83â–²(0.00% Upside)
Based on 16 Wall Street analysts offering 12 month price targets for Universal Health in the last 3 months. The average price target is CHF 165.83 with a high forecast of CHF 210.80 and a low forecast of CHF 131.54. The average price target represents a ― change from the last price of ―.
Highest Price TargetCHF210.80Average Price TargetCHF165.83Lowest Price TargetCHF131.54

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for CH:UHS
Price TargetArticle
Mizuho SecuritiesCHF189.72buy―Reiterated11/15/26
Cantor Fitzgerald―hold―Reiterated11/11/26
RBC CapitalCHF154.30→CHF174.54hold―Reiterated11/10/26
Goldman SachsCHF160.21hold―Reiterated11/09/26
Bank of America Securities―sell―Reiterated11/05/26
Wells FargoCHF139.97→CHF143.34hold―Assigned11/02/26
UBSCHF244.53→CHF210.80buy―Reiterated10/30/26
Morgan StanleyCHF161.05hold―Assigned10/29/26
KeyBanc―hold―Reiterated10/29/26
Robert W. BairdCHF139.97→CHF131.54hold―Reiterated10/29/26
TD CowenCHF166.11buy―Reiterated10/29/26
BarclaysCHF141.66hold―Reiterated10/28/26
GuggenheimCHF176.23→CHF169.48buy―Reiterated10/28/26
Raymond James―hold―Reiterated09/28/26
Leerink PartnersCHF166.95→CHF172.86buy―Reiterated09/18/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PVLAPalvella Therapeutics
IRLAIRulya Therapeutics
RZLTRezolute
PTGXProtagonist Therapeutics
CTMXCytomX Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Universal Health

3 Months
Whit Mayo
Whit MayoLeerink Partners
Success Rate22/32 ratings generated profit
69%
Average Return
+4.54%

Copying Whit Mayo's trades and holding each position for 3 Months would result in 68.75% of your transactions generating a profit, with an average return of +4.54% per trade.

1 Year
Ann Hynes
Ann HynesMizuho Securities
Success Rate19/26 ratings generated profit
73%
Average Return
+12.62%

Copying Ann Hynes's trades and holding each position for 1 Year would result in 73.08% of your transactions generating a profit, with an average return of +12.62% per trade.

2 Years
Jason Cassorla
Jason CassorlaGuggenheim
Success Rate13/16 ratings generated profit
81%
Average Return
+22.12%

Copying Jason Cassorla's trades and holding each position for 2 Years would result in 81.25% of your transactions generating a profit, with an average return of +22.12% per trade.

UHS Analyst Recommendation Trends

010203040Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for UHS
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy23320
Buy55546
Hold1312151314
Sell44322
Strong Sell00000
total2424262122

In the current month, UHS has received 6 Buy Ratings, 14 Hold Ratings, and 2 Sell Ratings. UHS average Analyst price target in the past 3 months is 165.83.

UHS Financial Forecast

CHF3CHF3.75CHF4.5CHF5.25CHF6Q1 2026Q3 2026Q4 2026
HighCHF5.13
ConsensusCHF4.74
LowCHF4.13

UHS Earnings Forecast

Next quarter’s earnings estimate for UHS is CHF 4.74 with a range of CHF 4.13 to CHF 5.13. The previous quarter’s EPS was CHF 4.40. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

CHF3.8BCHF3.9BCHF3.9BCHF4BCHF4.1BQ1 2026Q3 2026Q4 2026
HighCHF4.08B
ConsensusCHF4.01B
LowCHF3.91B

UHS Sales Forecast

Next quarter’s sales forecast for UHS is CHF 4.01B with a range of CHF 3.91B to CHF 4.08B. The previous quarter’s sales results were CHF 3.99B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

UHS Stock Forecast FAQ

What is CH:UHS’s average 12-month price target, according to analysts?
Based on analyst ratings, Universal Health’s 12-month average price target is CHF165.83.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Universal Health a Buy, Sell or Hold?
Universal Health has a consensus rating of Hold, which is based on 5 buy ratings, 10 hold ratings and 1 sell ratings.
What is Universal Health’s share price target?
The average share price target for Universal Health is CHF165.83. This is based on 16 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is CHF210.80, and the lowest forecast is CHF131.54. The average share price target represents a 0.00% increase from the current price of ―.
What do analysts say about Universal Health?
Universal Health’s analyst rating consensus is a Hold. This is based on the ratings of 16 Wall Street analysts.
How can I buy shares of Universal Health?
To buy shares of CH:UHS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.